P&G Hygiene and Health Care: Gaurav Bhartia to succeed Mrinalini Srinivasan as CFO
Mumbai: Procter & Gamble Hygiene and Health Care Limited has announced the appointment of Gaurav Bhartia as the new Chief Financial Officer (CFO), effective July 1, 2025.
This follows the resignation of Mrinalini Srinivasan, who will step down from the role at the close of business hours of June 30, 2025, to pursue interests outside the company. The Company places on record its appreciation for the services rendered by her and for her contributions to the Company, as per BSE filing.
Gaurav Bhartia currently leads Sales Finance for P&G India. He has a diverse experience spanning over a decade with P&G, across multiple categories and markets, leading transformational projects and delivering outstanding results for several important P&G businesses.
In his past assignments, Gaurav Bhartia has had significant contribution towards driving business growth and improving structural margins & profitability, while navigating macro-economic uncertainties.
Read also: Natco Pharma appoints Yarramshetty Krishna Rao as Senior Vice President - Operations at Mekaguda
He is passionate about coaching and invests time building capability for finance and broader multi-functional teams. He is a mentor to many in the organization and fosters a culture of performance and collaboration for sustained excellence. He is a strong advocate of P&G’s culture of simplification and efficiency.
Read also: Intas Pharma appoints Nitin Patel, Dr Rupesh Rane to key leadership roles
After a successful internship stint with P&G, he joined P&G full time in 2014 as a graduate from IIM Bangalore. He holds a B. Tech. degree from National Institute of Technology, Trichy.
"I hereby submit my resignation as Chief Financial Officer of the Company with effect from close of business hours of June 30, 2025, as I will be leaving Procter & Gamble to pursue other interests outside the Company. I would like to take this opportunity to thank the esteemed Board members for the support extended to me during my tenure," Srinivasan stated in her resignation letter to the company.
Read also: Intas Pharma ropes in Dr Vikas Sarangal as Deputy General Manager - Project Management
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.